It is typically recommended for patients with a body mass index (BMI) of 30 or higher, or 27 and above if there is an associated weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
Intangible Benefits and Quality of Life Value Cost-benefit analysis must also consider intangible benefits that affect quality of life but resist precise quantification
Robert Kushner, Northwestern University: GLP-1s are toolsnot magic bullets
Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, et al
Investors wait for the suit to shake out and Hims to scramble
In Canada, the non-formulary claims for GLP-1 RAs increased by more than fourfold from 14,088 claimants in 2016 to 60,120 claimants in 2021 [6]